felix semaglutide in the news! 📰 We were featured in both the Toronto Sun and The Globe and Mail this week on generic coming to Canada. Link in bio to read more Ad | Paid partnership with

doi: 10.3390/f12121649 145 WangP.JiaC.BushD.ZhouC.WengQ.LiF.et al

Not masculine-only but effective across the board

Pioneering research in Microdosing GLP-1 The AgelessRx Applied Science Team is leading the first clinical trial focused on the healthspan-enhancing potential of Microdosing GLP-1 Ongoing observational study including long-term tracking of diverse health outcomes in over 1,000 patients using a growing real-world database of patient-reported data Clinical collaborations are currently in development to expand the scope and impact of this research How it works GLP-1s bind to GLP-1 receptors beyond the brain and gut, reaching the heart, kidneys, blood vessels, and immune cells Shown to support signaling to longevity-related pathways like AMPK and mTOR, affecting key Hallmarks of Aging like oxidative stress, inflammation, DNA repair, mitochondrial function, and autophagy At low doses, may subtly restore balance to hormone signaling, reduce inflammation (immune cells), improve cognitive function, and cardiometabolic health Effects may vary based on individual biology and with factors including inflammation, weight, lifestyle, metabolic health, and health history

For beginners, the focus should be on conservative protocols that prioritize safety and gradual progression